TickerFactsScreenerDevelopers

Alaunos Therapeutics, Inc. (TCRT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$12.29M2010: -$19.69M2011: -$38.84M2012: -$78.83M2016: -$58.33M2017: -$54.67M2018: -$49.46M2019: -$40.85M2020: -$57.01M2021: -$61.47M2022: -$29.23M2023: -$30.14M2024: -$4.97M2025: -$2.87M-$2.87M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$2.87M+42.3%
2024-$4.97M+83.5%
2023-$30.14M-3.1%
2022-$29.23M+52.4%
2021-$61.47M-7.8%
2020-$57.01M-39.6%
2019-$40.85M+17.4%
2018-$49.46M+9.5%
2017-$54.67M+6.3%
2016-$58.33M—
2012-$78.83M-103.0%
2011-$38.84M-97.2%
2010-$19.69M-60.2%
2009-$12.29M—